The Evolution of Oxygen Concentrators
In the realm of medical technology, the journey of oxygen concentrators from their inception to their current cutting-edge designs showcases a remarkable tale of innovation and advancement. Originally conceived to provide supplemental oxygen therapy for respiratory patients,
The Lifesaving Importance of Oxygen
Oxygen is a fundamental element for sustaining life, and its critical role in healthcare cannot be overstated. Nowhere is this more evident than in the care of maternal and paediatric patients, where oxygen therapy plays a vital role in ensuring the health and well-being …
WHO Member States Meeting Statement
WHO Member States Meeting Statement National Oxygen Scale-Up Framework-Meeting: Road to Oxygen Access Statement In 2023, the World Health Assembly adopted the landmark…
PulmO2 Unveiling
Drive DeVilbiss Healthcare, a world leading manufacturer of oxygen solutions and Sanrai International, an expert in underserved markets, held the global unveiling of the new PulmO2 10 L Oxygen Concentrator.
Oxygen Co-Lab: Making Concentrators Fit for Purpose in Low Resource Settings
Amidst the chaos of the Covid-19 pandemic, a crucial issue came to light: oxygen concentrators built for well-resourced healthcare systems were being repurposed in vastly under-resourced environments worldwide. In such conditions, these machines struggled to withstand heat, humidity, and power outages, and were…
Oxygen Co-Lab: Announcing our new Research & Development Funding for oxygen concentrators
The Oxygen CoLab, funded by UK International Development, has spent the last three years working with partners from around the world to accelerate global access to oxygen in low-resource-settings.
Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management
In 2012, the World Health Organization revised treatment guidelines for childhood pneumonia …
Effectiveness of bubble continuous positive airway pressure for treatment of children aged 1–59 months with severe pneumonia and hypoxaemia in Ethiopia
A pragmatic cluster-randomised controlled trial
Clinical predictors of hypoxic pneumonia in children from the Eastern Highlands Province, Papua New Guinea
Secondary analysis of two prospective observational studies
Solar-powered oxygen delivery for the treatment of children with hypoxemia
Protocol for a cluster-randomized steppedwedge controlled trial in Uganda
